Cancer Family
Intraepithelial Neoplasia
CI-CAN-00000210Explore in graph →
Non-malignant79 active trials
- NCIt
- C8366
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000210Explore in graph →
Clinical trials
491 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03603808 | VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions | completed | Phase 2 | 44 | AIDS Malignancy ConsortiumNETWORK | 2 | Jul 8, 2026 | clinicaltrials |
| NCT02928978 | Ruxolitinib for Premalignant Breast Disease(TBCRC042) | completed | Phase 2 | 84 | Julie NangiaOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT02858310 |
| E7 TCR T Cells for Human Papillomavirus-Associated Cancers |
| completed |
| Phase 1 / Phase 2 |
| 224 |
| National Cancer Institute (NCI)NIH |
| 1 |
| Mar 9, 2026 |
| clinicaltrials |
| NCT02882282 | Pembrolizumab in Treating Patients With High Risk Oral Intraepithelial Neoplasia | completed | Phase 2 | 15 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 23, 2025 | clinicaltrials |
| NCT03300557 | Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer | completed | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Aug 29, 2025 | clinicaltrials |
| NCT05104099 | Evaluation of New Diagnostic Tool Using Fluorescence to Detect High-grade Vulvar Intraepithelial Neoplasia(PhotodiVIN) | completed | Phase 2 | 17 | Institut de Cancérologie de LorraineOTHER | 1 | Jul 24, 2025 | clinicaltrials |
| NCT05496231 | A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age | completed | Phase 1 / Phase 2 | 1,080 | GlaxoSmithKlineINDUSTRY | 8 | Feb 3, 2025 | clinicaltrials |
| NCT06601205 | Finasteride and Flutamide in Pre-surgical Trial in Prostate Cancer.(2F) | completed | Phase 2 / Phase 3 | 125 | Ente Ospedaliero Ospedali GallieraOTHER | 1 | Sep 19, 2024 | clinicaltrials |
| NCT02864147 | Treatment of High-Grade Pre-Neoplastic Cervical Lesions (CIN 2/3) | completed | Phase 2 | 134 | Yale UniversityOTHER | 1 | May 2, 2024 | clinicaltrials |
| NCT02481414 | A Clinical Trial of PepCan to Two Therapy Arms for Treating Cervical High-Grade Squamous Intraepithelial Lesions | completed | Phase 2 | 81 | University of ArkansasOTHER | 1 | Dec 18, 2023 | clinicaltrials |
| NCT03180684 | Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3) | completed | Phase 2 | 33 | Inovio PharmaceuticalsINDUSTRY | 1 | Aug 25, 2023 | clinicaltrials |
| NCT02740777 | Evaluating the 2-dose Immunization Schedule of Human Papillomavirus (HPV)-16/18 in Adolescent Females | completed | Phase 2 | 900 | Shanghai Zerun Biotechnology Co.,LtdINDUSTRY | 1 | Apr 13, 2023 | clinicaltrials |
| NCT02529930 | An Exploratory Safety and Immunogenicity Study of HPV16+ Immunotherapy VB10.16 in Women With HSIL; CIN 2/3) | completed | Phase 1 / Phase 2 | 34 | Nykode Therapeutics ASAINDUSTRY | 1 | Jul 13, 2022 | clinicaltrials |
| NCT03233412 | Randomized Clinical Trial Evaluating the Efficacy of Topical Imiquimod in High Grade Cervical Intraepithelial Lesions | completed | Phase 2 | 90 | Barretos Cancer HospitalOTHER | 1 | Feb 17, 2021 | clinicaltrials |
| NCT01443026 | The Effects of Lycopene on High Risk Prostatic Tissue | completed | Phase 2 | 66 | University of Illinois at ChicagoOTHER | 1 | Nov 19, 2019 | clinicaltrials |
| NCT02631863 | Aminolaevulinic Acid Photodynamic Therapy for HPV+ Low Grade Cervical Intraepithelial Neoplasia (LSIL;CIN1) | completed | Phase 2 | 60 | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jul 8, 2019 | clinicaltrials |
| NCT02304770 | Aminolaevulinic Acid Photodynamic Therapy of Cervical Persistent HPV Infection and Cervical Neoplasia | completed | Phase 2 | 73 | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jun 12, 2019 | clinicaltrials |
| NCT01304524 | A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3(HPV-003) | completed | Phase 2 | 167 | Inovio PharmaceuticalsINDUSTRY | 9 | Sep 7, 2018 | clinicaltrials |
| NCT00483327 | Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate | completed | Phase 2 | 31 | NYU Langone HealthOTHER | 1 | Apr 4, 2018 | clinicaltrials |
| NCT01923116 | Therapeutic HPV-16 Vaccination for the Treatment of Anal Dysplasia(VACCAIN-T) | completed | Phase 1 / Phase 2 | 40 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Mar 15, 2018 | clinicaltrials |
| NCT03293628 | Comparing Two Techniques of Haemostasis After Cervical Conization | completed | Phase 2 | 100 | Barretos Cancer HospitalOTHER | 1 | Sep 28, 2017 | clinicaltrials |
| NCT00081263 | Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia | completed | Phase 2 | 130 | Gynecologic Oncology GroupNETWORK | 1 | Sep 15, 2017 | clinicaltrials |
| NCT02139267 | Dose-finding, Safety Study of Plasmid DNA Therapeutic Vaccine to Treat Cervical Intraepithelial Neoplasia | completed | Phase 2 | 72 | Genexine, Inc.INDUSTRY | 1 | Jul 12, 2017 | clinicaltrials |
| NCT02130323 | Topical Imiquimod vs. LEEP for Women With Carcinoma In-situ of the Cervix | completed | Phase 2 / Phase 3 | 22 | United States Naval Medical Center, San DiegoFED | 1 | Jun 27, 2017 | clinicaltrials |
| NCT01022346 | A Study of RO5217790 in Participants With High Grade Cervical Intraepithelial Neoplasia (CIN) Associated With High Risk Human Papillomavirus (HR-HPV) Infection | completed | Phase 2 | 206 | Hoffmann-La RocheINDUSTRY | 6 | Aug 15, 2016 | clinicaltrials |
| NCT01256424 | Dose-finding Study of Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) to Treat Cervical Neoplasia | completed | Phase 2 | 262 | PhotocureINDUSTRY | 2 | May 16, 2016 | clinicaltrials |
| NCT02195089 | Efficacy and Safety Study of BLS_ILB_E710c for the Fertile Women With Cervical Intraepithelial Neoplasia(CIN3) | completed | Phase 1 / Phase 2 | 19 | BioLeaders CorporationINDUSTRY | 1 | Apr 19, 2016 | clinicaltrials |
| NCT00154089 | A Pilot Study of EM-1421 for the Treatment of Cervical Intraepithelial Neoplasia | completed | Phase 1 / Phase 2 | 8 | Erimos PharmaceuticalsINDUSTRY | 1 | Feb 23, 2016 | clinicaltrials |
| NCT01826045 | Efficacy and Safety Study of PGA (Poly-gamma Glutamic Acid) for Cervical Intraepithelial Neoplasia(PGA) | completed | Phase 2 | 200 | BioLeaders CorporationINDUSTRY | 1 | Jan 29, 2016 | clinicaltrials |
| NCT01986725 | The Impact of the "WOMAN-PRO II Program" on Patients With Vulvar Neoplasia to Minimize Post-surgical Symptom Prevalence(WOMAN-PROII) | completed | Phase 2 | 45 | St.Gallen University of Applied SciencesOTHER | 1 | Jan 7, 2016 | clinicaltrials |
| NCT01356823 | Dose-Ranging Study of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine | completed | Phase 2 | 1,600 | Xiamen UniversityOTHER | 1 | Jan 5, 2016 | clinicaltrials |
| NCT01192204 | Clinical Evaluation of Bioadhesive Gels for Oral Cancer Chemoprevention | completed | Phase 1 / Phase 2 | 41 | Ohio State UniversityOTHER | 1 | Aug 14, 2015 | clinicaltrials |
| NCT01405768 | Buffered Lidocaine for Loop Electrosurgical Excision Procedures (LEEPs) | completed | Phase 2 | 56 | Washington University School of MedicineOTHER | 1 | Jul 28, 2014 | clinicaltrials |
| NCT02184975 | Cold Knife Conization With and Without Lateral Hemostatic Sutures | completed | Phase 2 | 100 | Barretos Cancer HospitalOTHER | 1 | Jul 9, 2014 | clinicaltrials |
| NCT00028353 | A Chemoprevention Study of an Investigational Drug in Men With High Grade Prostate Intraepithelial Neoplasia (PIN) | completed | Phase 2 | 500 | GTxINDUSTRY | 1 | Nov 15, 2013 | clinicaltrials |
| NCT00091130 | SGN-00101 Vaccine in Treating Human Papillomavirus in Patients Who Have Abnormal Cervical Cells | completed | Phase 2 | 139 | National Cancer Institute (NCI)NIH | 1 | Jun 3, 2013 | clinicaltrials |
| NCT00264732 | A Study of Amolimogene (ZYC101a) in Patients With High Grade Cervical Intraepithelial Lesions of the Uterine Cervix | completed | Phase 2 / Phase 3 | 251 | Eisai Inc.INDUSTRY | 1 | May 29, 2013 | clinicaltrials |
| NCT01303328 | Safety and Efficacy Study of Antiviral Local Application to Treat High Grade Cervical Intraepithelial Lesions (CIN2/3)(Colvir-PhaseII) | completed | Phase 2 | 200 | Mithra PharmaceuticalsINDUSTRY | 1 | Feb 18, 2013 | clinicaltrials |
| NCT00247169 | Vaginal Progesterone in the Treatment of Cervical Dysplasia Grade I and II | completed | Phase 2 | 40 | Medical University of ViennaOTHER | 1 | Mar 9, 2012 | clinicaltrials |
| NCT00941252 | ITIC (Imiquimod Therapy in Cervical Intraepithelial Neoplasia)-Trial(ITIC) | completed | Phase 2 / Phase 3 | 60 | Medical University of ViennaOTHER | 1 | Jan 24, 2011 | clinicaltrials |
| NCT00369018 | A Dose-finding Study of MAL and HAL Photodynamic Therapy of Cervical Premalignant Lesions. | completed | Phase 1 / Phase 2 | 96 | PhotocureINDUSTRY | 2 | Nov 30, 2010 | clinicaltrials |
| NCT00285207 | Safety and Efficacy of A-007 Topical Gel in the Treatment of High-Grade Squamous Intraepithelial Lesions (HSIL) of the Cervix | completed | Phase 2 | 147 | Tigris PharmaceuticalsINDUSTRY | 1 | Oct 11, 2010 | clinicaltrials |
| NCT00190983 | A Trial for Patients With Advanced/Recurrent Cervical Cancer | completed | Phase 2 | 29 | Eli Lilly and CompanyINDUSTRY | 1 | Nov 20, 2009 | clinicaltrials |
| NCT00596258 | A Two-Stage Phase 2 Study Of A-007 Topical Gel in High-Grade Squamous Intraepithelial Lesions (HSIL)(TG-003) | completed | Phase 2 | 11 | Tigris PharmaceuticalsINDUSTRY | 1 | May 22, 2009 | clinicaltrials |
Data updated 22 days agoSource updated Jul 8, 2026source: clinicaltrials